11
Mar
Andrew Kathindi and Kandjemuni Kamuiiri The Ministry of Health and Social Services (MoHSS) is forging ahead with the procurement of AstraZeneca through the COVAX Facility, despite confirming that the South African variant of COVID-19 known as 501.V2, is in Namibia. Health Minister Kalumbi Shangula confirmed to Windhoek Observer that the Namibia will still receive AstraZeneca through the COVAX Facility, but, however downplayed its ineffectiveness against the variant. On why Namibia is going ahead with procuring a vaccine that studies deemed ineffective, Shangula said, “No, no, don't say so. You have no evidence or grounds to say it is useless. Those…